SCHEMBL4110971

SCHEMBL4110971

COc1cccc(C(=O)c2cc(Cl)ccc2-n2c(C=O)nc(Cl)c2Cl)c1OC.COc1cccc(C(=O)c2cc(Cl)ccc2-n2cnc(Cl)c2Cl)c1OC

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
HSD17B10 Q99714 2/20 0.32
GAA P10253 1/20 0.32
RORC P51449 1/20 0.32
RORB Q92753 1/20 0.32
KDM4E B2RXH2 2/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPT P10636 2/20 0.32
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4112572 0.92 HCRTR1 (0.37) KMT2AALDH1A1HCRTR1HCRTR2HSD17B10
SCHEMBL13775802 0.89 KMT2A (0.40) KMT2AALDH1A1HCRTR1HCRTR2HSD17B10
SCHEMBL4124318 0.82 KDM4E (0.37) ALDH1A1HCRTR1HCRTR2HSD17B10RORC
SCHEMBL4124313 0.82 KDM4E (0.37) ALDH1A1HCRTR1HCRTR2HSD17B10RORC
SCHEMBL4111361 0.81 HCRTR1 (0.38) KMT2AALDH1A1HCRTR1HCRTR2HSD17B10
SCHEMBL4120170 0.80 RORB (0.39) KMT2AALDH1A1GAARORCRORB
SCHEMBL13775493 0.78 L3MBTL1 (0.37) KMT2AALDH1A1HCRTR1HCRTR2KDM4E
SCHEMBL4118412 0.78 HPGD (0.41) KMT2AALDH1A1HCRTR1HCRTR2HSD17B10
SCHEMBL13775799 0.76 ALDH1A1 (0.40) KMT2AALDH1A1HCRTR1HCRTR2HSD17B10
SCHEMBL4123934 0.75 GAA (0.51) ALDH1A1GAAKDM4ENPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR KMT2A 1467/4885ALDH1A1 1587/4885HCRTR1 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.